Parameter,Description
m1,number of enrolled patients who are CTA+ and randomly assigned to treatment or control
m,the total number of screened patients with valid CTA results (eligible for bridging study)
n11,number of CTA+ and CDx+ out of n1
n1,number of CTA+ patients enrolled in bridging (concordance) study
n01,number of CTA- and CDx+ out of n0
n0,number of CTA- patients enrolled in bridging (concordance) study
orr,single-arm objective response rate in subgroup CDA+ and CDx+
c,"proportion of delta2/delta1, where delta2 is efficacy in CDA- and CDx+"
